Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients ; volume:8 ; number:1 ; day:15 ; month:1 ; year:2008 ; pages:1-8 ; date:12.2008
BMC cancer ; 8, Heft 1 (15.1.2008), 1-8, 12.2008

Creator: Cho, Byoung Chul

Contributor: Ahn, Joong Bae
Seong, Jinsil
Roh, Jae Kyung
Kim, Joo Hang
Chung, Hyun Cheol
Sohn, Joo Hyuk
Kim, Nam Kyu
SpringerLink (Online service)

DOI: 10.1186/1471-2407-8-8

URN: urn:nbn:de:1111-2016030347465

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cho, Byoung Chul
Ahn, Joong Bae
Seong, Jinsil
Roh, Jae Kyung
Kim, Joo Hang
Chung, Hyun Cheol
Sohn, Joo Hyuk
Kim, Nam Kyu
SpringerLink (Online service)

Other Objects (12)

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Hochschulschrift

Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Hochschulschrift

Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Hochschulschrift

Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial

Related objects

Reset password